chr15-91252371-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001323032.3(SV2B):āc.635T>Cā(p.Ile212Thr) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000762 in 1,610,024 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00055 ( 1 hom., cov: 32)
Exomes š: 0.00078 ( 1 hom. )
Consequence
SV2B
NM_001323032.3 missense, splice_region
NM_001323032.3 missense, splice_region
Scores
12
7
Clinical Significance
Conservation
PhyloP100: 4.91
Genes affected
SV2B (HGNC:16874): (synaptic vesicle glycoprotein 2B) This gene encodes a member of the synaptic vesicle proteins 2 (SV2) family and major facilitator superfamily of proteins. This protein and other members of the family are localized to synaptic vesicles and may function in the regulation of vesicle trafficking and exocytosis. Studies in mice suggest that the encoded protein may act as a protein receptor for botulinum neurotoxin E in neurons, and that this protein may be important for the integrity of the glomerular filtration barrier. This gene shows reduced expression in areas of synaptic loss in the hippocampus of human temporal lobe epilepsy patients. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.01856199).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SV2B | NM_001323032.3 | c.635T>C | p.Ile212Thr | missense_variant, splice_region_variant | 4/13 | ENST00000394232.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SV2B | ENST00000394232.6 | c.635T>C | p.Ile212Thr | missense_variant, splice_region_variant | 4/13 | 5 | NM_001323032.3 | P1 | |
SV2B | ENST00000330276.4 | c.635T>C | p.Ile212Thr | missense_variant, splice_region_variant | 3/12 | 1 | P1 | ||
SV2B | ENST00000557410.5 | c.635T>C | p.Ile212Thr | missense_variant, splice_region_variant, NMD_transcript_variant | 5/15 | 1 | |||
SV2B | ENST00000545111.6 | c.182T>C | p.Ile61Thr | missense_variant, splice_region_variant | 3/12 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000552 AC: 84AN: 152172Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
84
AN:
152172
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000679 AC: 167AN: 245864Hom.: 0 AF XY: 0.000661 AC XY: 88AN XY: 133036
GnomAD3 exomes
AF:
AC:
167
AN:
245864
Hom.:
AF XY:
AC XY:
88
AN XY:
133036
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000784 AC: 1143AN: 1457734Hom.: 1 Cov.: 31 AF XY: 0.000764 AC XY: 554AN XY: 725028
GnomAD4 exome
AF:
AC:
1143
AN:
1457734
Hom.:
Cov.:
31
AF XY:
AC XY:
554
AN XY:
725028
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000552 AC: 84AN: 152290Hom.: 1 Cov.: 32 AF XY: 0.000470 AC XY: 35AN XY: 74470
GnomAD4 genome
AF:
AC:
84
AN:
152290
Hom.:
Cov.:
32
AF XY:
AC XY:
35
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
79
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.635T>C (p.I212T) alteration is located in exon 5 (coding exon 3) of the SV2B gene. This alteration results from a T to C substitution at nucleotide position 635, causing the isoleucine (I) at amino acid position 212 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
.;D;D
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
.;M;M
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
0.25
.;B;B
Vest4
MVP
MPC
0.39
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at